<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2022.889564</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>T Cell Specific BOB.1/OBF.1 Expression Promotes Germinal Center Response and T Helper Cell Differentiation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Betzler</surname>
<given-names>Annika C.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1231549"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ezi&#x107;</surname>
<given-names>Jasmin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Abou Kors</surname>
<given-names>Tsima</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1785078"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hoffmann</surname>
<given-names>Thomas K.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1279463"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wirth</surname>
<given-names>Thomas</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1254221"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Brunner</surname>
<given-names>Cornelia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/473025"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Oto-Rhino-Laryngology, Ulm University Medical Center</institution>, <addr-line>Ulm</addr-line>, <country>Germany</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Physiological Chemistry, Ulm University</institution>, <addr-line>Ulm</addr-line>, <country>Germany</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Cosima T. Baldari, University of Siena, Italy</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Lars Nitschke, University of Erlangen Nuremberg, Germany; Andreas Hutloff, University Hospital Schleswig-Holstein, Germany</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Cornelia Brunner, <email xlink:href="mailto:cornelia.brunner@uniklinik-ulm.de">cornelia.brunner@uniklinik-ulm.de</email>
</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to T Cell Biology, a section of the journal Frontiers in Immunology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>04</day>
<month>05</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>889564</elocation-id>
<history>
<date date-type="received">
<day>04</day>
<month>03</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>04</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Betzler, Ezi&#x107;, Abou Kors, Hoffmann, Wirth and Brunner</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Betzler, Ezi&#x107;, Abou Kors, Hoffmann, Wirth and Brunner</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>The transcriptional co-activator BOB.1/OBF.1 is expressed in both B and T cells. The main characteristic of conventional BOB.1/OBF.1 deficient mice is the complete absence of germinal centers (GCs). This defect was mainly attributed to the defective B cell compartment. However, it is unknown whether and how BOB.1/OBF.1 expression in T cells contributes to the GC reaction. To finally clarify this question, we studied the <italic>in vivo</italic> function of BOB.1/OBF.1 in CD4<sup>+</sup> T and follicular T helper (TFH) cell subpopulations by conditional mutagenesis, in the presence of immunocompetent B lymphocytes. BOB.1/OBF.1 deletion in CD4<sup>+</sup> T as well as TFH cells resulted in impaired GC formation demonstrating that the impaired GC reaction described for conventional BOB.1/OBF.1-deficient mice cannot exclusively be traced back to the B cell compartment. Furthermore, we show a requirement of BOB.1/OBF.1 for T helper (TH) cell subsets, particularly for TFH cell differentiation.</p>
</abstract>
<kwd-group>
<kwd>BOB.1/OBF.1</kwd>
<kwd>germinal center</kwd>
<kwd>T cell differentiation</kwd>
<kwd>follicular T helper cells</kwd>
<kwd>humoral immunity</kwd>
<kwd>transcriptional co-activator</kwd>
<kwd>Pou2af1</kwd>
</kwd-group>
<contract-sponsor id="cn001">Deutsche Forschungsgemeinschaft<named-content content-type="fundref-id">10.13039/501100001659</named-content>
</contract-sponsor>
<counts>
<fig-count count="7"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="65"/>
<page-count count="15"/>
<word-count count="7577"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>BOB.1/OBF.1 (also known as OCA-B), encoded by the <italic>Pou2af1</italic> (POU domain class 2-associating factor 1) gene, is a lymphocyte-restricted transcriptional co-activator involved in octamer-dependent transcription (<xref ref-type="bibr" rid="B1">1</xref>). The octamer motif (5&#x2019;-ATGCAAAT-3&#x2019;) is found in all immunoglobulin (Ig) heavy and light chain gene promoters as well as enhancer elements (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>). Octamer-dependent transcription is achieved by transcription factors (TFs) belonging to the Oct-family including Oct-1 and Oct-2. The Oct-1 protein is ubiquitously expressed, whereas the Oct-2 protein is specific for cells of hematopoietic origin (<xref ref-type="bibr" rid="B4">4</xref>). The binding selectivity to the octamer motif and the transcriptional activity of these Oct transcriptions factors can be enhanced by the additional recruitment of BOB.1/OBF.1. The transcriptional regulator BOB.1/OBF.1 itself has a low affinity to DNA but is instead recruited to the octamer motif by its direct interaction with Oct TFs (<xref ref-type="bibr" rid="B5">5</xref>&#x2013;<xref ref-type="bibr" rid="B8">8</xref>). Thus, BOB.1/OBF.1 activates octamer-dependent transcription by its synergistic interaction with Oct proteins, thereby regulating the expression of genes essential for lymphocyte physiology. BOB.1/OBF.1 has long been considered a B cell specific factor and is mainly studied in B cells. Thereby it has been shown that BOB.1/OBF.1 is constitutively expressed in B lymphocytes, where its highest expression level was observed in germinal center (GC) B cells (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>). BOB.1/OBF.1 deficiency leads to B cell developmental defects in the bone marrow as well as to later defects observed in the periphery (<xref ref-type="bibr" rid="B11">11</xref>&#x2013;<xref ref-type="bibr" rid="B14">14</xref>). BOB.1/OBF.1-deficient mice feature severely reduced splenic B cells and impaired follicular B cell maturation (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>). BOB.1/OBF.1 is additionally required for marginal zone B cell development and function (<xref ref-type="bibr" rid="B13">13</xref>). The hallmark of BOB.1/OBF.1-deficient animals is the complete absence of GCs and consequently severely reduced levels of secondary Igs and the failure to generate post-GC B cells (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B16">16</xref>), caused by the combined binding of BOB.1/OBF.1 together with Oct TFs to genes important for GC formation in mouse and human GC B cells controlling their transcriptional program (<xref ref-type="bibr" rid="B17">17</xref>).</p>
<p>On the other hand, the role and function of BOB.1/OBF.1 in T cells is poorly understood. In CD4<sup>+</sup> T cells, BOB.1/OBF.1 expression can be induced upon treatment with PMA/Ionomycin or antigen receptor engagement (<xref ref-type="bibr" rid="B18">18</xref>&#x2013;<xref ref-type="bibr" rid="B20">20</xref>). There is evidence that NFAT, together with NF&#x3ba;B TFs, controls the expression of BOB.1/OBF.1 thereby regulating octamer-dependent transcription in T cells (<xref ref-type="bibr" rid="B20">20</xref>). Previously, we observed a role of BOB.1/OBF.1 to control TH1/TH2 cytokine balance and its influence on <italic>IL-2</italic> and <italic>INF&#x3b3;</italic> promoter activities (<xref ref-type="bibr" rid="B21">21</xref>). Moreover, reports from our and other groups revealed that the development and function of follicular T helper (TFH) cells involve BOB.1/OBF.1 (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>). Thus, a direct contribution of BOB.1/OBF.1 to the promoter activity of <italic>Bcl6</italic>, the master regulator of TFH cell lineage, was shown (<xref ref-type="bibr" rid="B22">22</xref>). In addition, a requirement of BOB.1/OBF.1 together with Oct-1 for the generation and function of CD4<sup>+</sup> memory T cells was suggested (<xref ref-type="bibr" rid="B24">24</xref>). Most recently, a role for BOB.1/OBF.1 in TH17 differentiation and in the regulation of IL17A production was described (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>).</p>
<p>Over the last years, a role for BOB.1/OBF.1 also in the human immune system has become more and more evident. A patient with a mutation in the <italic>Pou2af1</italic> gene leading to the absence of BOB.1/OBF.1 protein was described with B cell developmental defects, agammaglobulinemia and a reduction in circulating TFH cells (<xref ref-type="bibr" rid="B27">27</xref>). Beyond that, dysregulated expression of BOB.1/OBF.1 in both B and T cells was described to contribute to the pathogenesis of several autoimmune diseases including Rheumatoid arthritis, Type 1 diabetes, multiple sclerosis and systemic lupus erythematosus (<xref ref-type="bibr" rid="B28">28</xref>&#x2013;<xref ref-type="bibr" rid="B30">30</xref>). Thus, BOB.1/OBF.1 might be a promising pharmacological target for certain immune-related diseases.</p>
<p>Therefore, a better understanding of BOB.1/OBF.1 functions and its possible target genes is necessary. Especially, the question whether the expression of BOB.1/OBF.1 in T cells contributes to the GC reaction is still controversially discussed (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B31">31</xref>). To finally clarify whether and how BOB.1/OBF.1 expression in T cells contributes to the GC reaction, we now generated a mouse model enabling the regulation of BOB.1/OBF.1 expression specifically in defined T cell subpopulations that contribute to the GC reaction, in the presence of a functional B cell compartment.</p>
<p>Here we studied the <italic>in vivo</italic> function of BOB.1/OBF.1 in distinct T cell subpopulations by conditional mutagenesis. Using this mouse system, we analyzed the consequences of deleting BOB.1/OBF.1 precisely in CD4<sup>+</sup> T cells as well as TFH cells. Contrary to previous assumptions, we provide evidence that the impaired GC reaction described for conventional BOB.1/OBF.1-deficient mice cannot exclusively be traced back to the B cell compartment, since BOB.1/OBF.1 deletion in CD4<sup>+</sup> T as well as TFH cells also resulted in impaired GC formation. Furthermore, our data show a contribution of BOB.1/OBF.1 for T helper (TH) and especially TFH cell differentiation. RNA-seq analysis identified several genes among the top 30 differentially expressed genes (DEGs) in Pou2af1<sup>fl/fl</sup> x CD4-Cre mice involved in T cell differentiation and function.</p>
</sec>
<sec id="s2">
<title>Material and Methods</title>
<sec id="s2_1">
<title>Mice and Immunization</title>
<p>Mice were bred on the C57BL/6JRj background and maintained under specific pathogen-free conditions at the animal facility of Ulm University. The Pou2af1<sup>fl/fl</sup> mice (C57BL/6JRj background) were crossed to CD4-Cre (<xref ref-type="bibr" rid="B32">32</xref>) or IL21-Cre mice (<xref ref-type="bibr" rid="B33">33</xref>). Animal experimentation was done in accordance with German legislation for animal protection (reference number: 35/9185.81-3/1325). Mice were maintained in a specific pathogen-free facility under standard housing conditions with continuous access to food and water. Mice used in the study were 8-14-weeks old and were maintained on 12&#x2009;h light, 12&#x2009;h dark light cycle (6:00-18:00). To test T-dependent antibody responses and Germinal Center reaction, mice were immunized with 10<sup>8</sup> Sheep Red Blood Cells (SRBCs) (Cedarlane Laboratories, Canada) in PBS by i.p. injection. To analyze antibody production during a secondary immune response, mice were immunized on day 0 and again on day 14. Blood was collected on days 0, 14 and 21. To assess antigen-specific antibody levels, mice were immunized with 100 &#xb5;g NP-KLH (Biosearch Technologies) emulsified in Imject Alum (Thermo Fisher Scientific) by i.p injection. Serum was analyzed for the presence of antigen-specific immunoglobulins after 28 days.</p>
</sec>
<sec id="s2_2">
<title>Generation of Floxed <italic>Pou2af1</italic> Alleles</title>
<p>The strategy for the generation of a conditional Pou2af1 allele is described elsewhere (<xref ref-type="bibr" rid="B34">34</xref>).</p>
</sec>
<sec id="s2_3">
<title>T Cell Purification and Immunoblot Analysis</title>
<p>To examine the expression of BOB.1/OBF.1 in CD4<sup>+</sup> T cells in the respective mouse strains, T cells were enriched by a magnetic column. Appropriate kits were used to isolate CD4<sup>+</sup> T cells (Milteny Biotec). TFH cells were sorted on a BD FACS Aria cell sorter (BD Biosciences) based on their expression of CD3, CD4, CXCR5 and PD-1. Due to limited number of sorted TFH cells, cells were pooled from two or three mice of respective genotypes. Isolated or sorted cells were lysed in RIPA buffer and immunoblotting was performed following standard procedures using the following antibodies: anti-BOB.1/OBF.1 (self-made) and anti-&#x3b2;-actin (Sigma-Aldrich, Missouri, USA). Horseradish-peroxidase conjugated rabbit anti-mouse antibody was used as a secondary antibody. Membranes were developed with a chemiluminescence detection system (Bio-Rad, California, USA).</p>
</sec>
<sec id="s2_4">
<title>Flow-Cytometric Analysis</title>
<p>The cell staining procedure was described earlier (<xref ref-type="bibr" rid="B34">34</xref>). Data were acquired on a Gallios cytometer (Beckman Coulter, California, USA) and analyzed with Kaluza Analysis software, version 2.1 (Beckman Coulter, California, USA). Used antibodies are summarized in <xref ref-type="supplementary-material" rid="SM1">
<bold>Table&#xa0;S1</bold>
</xref>. Intracellular Foxp3 staining was performed using the Treg detection kit (Milteny Biotec).</p>
</sec>
<sec id="s2_5">
<title>Immunohistochemistry</title>
<p>Paraffin-embedded sections of spleens from immunized mice were stained with biotinylated Peanut Agglutinin (PNA) (Vector Laboratories, California, USA). This was followed by detection with horseradish-peroxidase conjugated streptavidin and AEC chromogen. Subsequently, slides were counter stained with hematoxylin.</p>
</sec>
<sec id="s2_6">
<title>Enzyme-Linked Immunosorbent Assay (ELISA)</title>
<p>Immunoglobulin ELISA was performed as previously described (<xref ref-type="bibr" rid="B34">34</xref>). For determination of NP-specific antibody levels in sera from 28 d NP-KLH immunized mice ELISA plates were coated overnight at 4&#xb0;C with 10 &#xb5;g/ml NP(9)- and NP(27)-BSA. The next day, plates were blocked with 5% BSA in PBS overnight at 4&#xb0;C. Subsequently, plates were washed, and serum samples were serially diluted in duplicate and incubated overnight at 4&#xb0;C. Plates were then washed and incubated with alkaline phosphatase-conjugated goat anti-mouse IgM, IgG1 or IgG3 (SouthernBiotech, USA) diluted 1:1000 for 1h at 37&#xb0;C. 4-nitrophenil phosphate-disodium salt (Serva, Germany) was used as substrate. Plates were read in a plate reader at 450 nm. Values were reported as relative absorbance.</p>
</sec>
<sec id="s2_7">
<title>Cell Isolation, RNA Extraction and Sequencing</title>
<p>CD4<sup>+</sup> T cells were isolated from LNs of CD4-Cre (n=4) and Pou2af1<sup>fl/fl</sup> x CD4-Cre (n=9) mice after immunization with SRBCs by magnetic separation using CD4<sup>+</sup> T cell isolation kit (Milteny Biotec). Purity of isolated CD4<sup>+</sup> T cells was &#x2265; 96% for all samples and is shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S14</bold>
</xref>. Extraction and purification of RNA were performed using RNeasy Mini Kit (Qiagen). RNA was eluted in RNase-free water and stored at -80&#xb0;C. RNA quantity was measured using the Infinite 200 Pro (Tecan).</p>
<p>Quality was checked using an Agilent Tape Station and all samples displayed RIN values above 9. After quantity measurement by Qubit Fluorometer (Invitrogen) 200ng of RNA were used to generate sequencing libraries using the Illumina RNA-Seq Kit V2. Sequencing libraries were subsequently quality checked on D1000 screentapes (Agilent) and 10 samples each were sequenced using a NextSeq550 (Illumina) and 2 NextSeq 500/550 High Output Kits v2.5 (75 Cycles) at the Genomics Core Facility (Ulm University).</p>
</sec>
<sec id="s2_8">
<title>Read Mapping and Quantification</title>
<p>Hiqh-quality reads were mapped to the mouse genome (GRChm38) using STAR (2.0.9). Followed by the removal of multimapping reads, converted to gene specific read counts for annotated genes using featureCounts (2.0.0).</p>
</sec>
<sec id="s2_9">
<title>Differential Expression Analysis</title>
<p>Data analysis was performed in R (4.0.2) using the IDE Rstudio (1.3.1056). Differential expression analysis was performed using deseq2 (1.29.16), and the shrinkage estimator used was &#x201c;apeglm&#x201d; (<xref ref-type="bibr" rid="B35">35</xref>). For computation of distance matricies, euclidian distance was used. Generally, ggplot2 (3.3.2) was used for data visualization. The 99<sup>th</sup> percentile of the log2foldchanges was calculated (<xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S15</bold>
</xref>) and applied as a cutoff alongside an FDR cutoff of 0.05. This cutoff corresponds to an absolute foldchange of 1.1327. Clustering in the heatmaps was done using hierarchical clustering within the pheatmap (1.0.12) package. Gene ontology and visualization of the results was performed using clusterProfiler (3.18.0) and enrichplot (1.11.0.991). UMAP dimensionallity reduction has been performed using the package uwot (0.1.8), with the default parameters (except: n_neighbors = n/2). Waterfall plots were created using R (4.1.1) and the ggplot2 (3.3.5) package.</p>
</sec>
<sec id="s2_10">
<title>Statistical Analysis</title>
<p>Results are expressed as arithmetic means &#xb1; standard deviation. Statistical analysis was performed with a two-tailed unpaired Student&#x2019;s t-test or Mann-Whitney-U test as indicated, with GraphPad Prism V8 software. * p &lt; 0.05, ** p &lt; 0.01, *** p &lt; 0.001, **** p &lt; 0.0001.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>Conditional Deletion of Pou2af1 in CD4<sup>+</sup> T Cells as Well as TFH Cells</title>
<p>To address the role of BOB.1/OBF.1 in T lymphocytes, we generated floxed <italic>Pou2af1</italic> alleles, as previously described (<xref ref-type="bibr" rid="B34">34</xref>). To assess the T lymphoid function of BOB.1/OBF.1, we used the CD4- (<xref ref-type="bibr" rid="B32">32</xref>) and IL21-Cre (<xref ref-type="bibr" rid="B33">33</xref>) mice. CD4-Cre was chosen to specifically delete BOB.1/OBF.1 in double positive and mature T cells. IL21-Cre mice were used to address the role of BOB.1/OBF.1 predominantly in TFH cells, key regulators of the GC response. IL21 is primarily produced by TFH cells, but a production from TH17 and natural killer T cells has also been reported (<xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B37">37</xref>). Since IL21 is also required for TFH cell differentiation, it is already upregulated in developing pre-TFH cells (<xref ref-type="bibr" rid="B38">38</xref>). Thus, crossing Pou2af1<sup>fl/fl</sup> mice to IL21-Cre mice results in BOB.1/OBF.1 deficiency already in pre-TFH cells and not specifically in fully developed TFH cells. The <italic>Pou2af1</italic> mRNA contains two translation initiation codons leading to the expression of two different isoforms &#x2013; p40 and p34 (<xref ref-type="bibr" rid="B39">39</xref>). The transient p40-isoform serves as a precursor of a third p35 isoform, which is why predominantly the p34 and p35 isoform are detectable by immunoblot analysis. Conditional deletion of both p34 and p35 isoforms of BOB.1/OBF.1 in CD4<sup>+</sup> T and TFH cells was confirmed by immunoblot analysis (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1A, B</bold>
</xref>). BOB.1/OBF.1 is completely absent in CD4<sup>+</sup> T cells isolated from Pou2af1<sup>fl/fl</sup> x CD4-Cre mice and CXCR5<sup>+</sup> PD-1<sup>+</sup> TFH cells isolated from Pou2af1<sup>fl/fl</sup> x IL21-Cre mice. For all analyses, we compared the conditional knockouts to their respective Cre- and floxed-controls, ruling out any Cre- or floxed-dependent effects. Both Cre- and floxed-genes are functionally WT. For comparison, we included WT C57BL/6JRj and conventional Pou2af1 knockout mice generated by Nielsen et&#xa0;al., in which BOB.1/OBF.1 is deleted in all cell types permanently/stably (<xref ref-type="bibr" rid="B14">14</xref>). Both conditional knockouts are generally healthy and fertile. CD4-Cre or IL21-Cre expression itself have no effect on thymic T cell development (<xref ref-type="bibr" rid="B40">40</xref>) (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Conditional deletion of Pou2af1 in CD4<sup>+</sup> T cells as well as TFH cells. <bold>(A, B)</bold> p34 and p35 BOB.1/OBF.1 isoform protein levels in CD4<sup>+</sup> T <bold>(A)</bold> and TFH <bold>(B)</bold> cells were determined by immunoblotting, respectively. &#x3b2;-actin was used as loading control. <bold>(C)</bold> Representative flow cytometry plots of T cell development in the thymus of respective Cre-controls and conditional knockouts are shown. Gating strategy is shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S7</bold>
</xref>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-889564-g001.tif"/>
</fig>
</sec>
<sec id="s3_2">
<title>BOB.1/OBF.1 Deficiency in CD4<sup>+</sup> T Cells Alters the CD4/CD8 T Cell Ratio in the Periphery</title>
<p>First, we investigated the effect of conditional BOB.1/OBF.1 ablation on the T cell compartment in the periphery. Beforehand, numbers of splenocytes of both Pou2af1<sup>fl/fl</sup> crossed either to CD4- or IL21-Cre mice were comparable to the WT situation (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). Similarly, the overall number of CD3<sup>+</sup> T cells was unaffected in both conditional knockouts in spleen and LNs (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S1A</bold>
</xref>). However, the number of CD4<sup>+</sup> T cells was significantly reduced in Pou2af1<sup>fl/fl</sup> x CD4-Cre mice in spleen and LN (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S1B</bold>
</xref>). The reduction of splenic CD4<sup>+</sup> T cells observed in Pou2af1<sup>fl/fl</sup> x CD4-Cre was comparable to conventional BOB.1/OBF.1-deficient animals. On the other hand, CD8<sup>+</sup> T cell numbers were significantly increased in Pou2af1<sup>fl/fl</sup> x CD4-Cre mice both in spleen and LN (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2D</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S1C</bold>
</xref>). Numbers of CD4<sup>+</sup> and CD8<sup>+</sup> T cells in Pou2af1<sup>fl/fl</sup> x Il21-Cre mice were comparable to the WT situation (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2C, D</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Figures S1B, C</bold>
</xref>). In accordance with cell numbers, Pou2af1<sup>fl/fl</sup> x CD4-Cre mice featured markedly reduced percentages of CD4<sup>+</sup> T cells, while at the same time increased percentages of CD8<sup>+</sup> T cells resulting in a significantly altered CD4/CD8 T cell ratio in comparison to controls both in spleen and LN (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2E</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S1D</bold>
</xref>). The CD4/CD8 ratio in the spleen and LN of Pou2af1<sup>fl/fl</sup> x Il21-Cre mice was unaffected (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2E</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S1D</bold>
</xref>). B cell numbers in both conditional knockouts were comparable to the WT situation in spleen and LN (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2F</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S1E</bold>
</xref>). These results suggest a role for BOB.1/OBF.1 in CD4<sup>+</sup> T cell biology.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>BOB.1/OBF.1 deficiency in CD4<sup>+</sup> T cells alters the CD4/CD8 T cell ratio in the periphery. <bold>(A)</bold> Statistical representation of the number of splenocytes after lysis of erythrocytes. <bold>(B&#x2013;D)</bold> Statistical representation of CD3<sup>+</sup> <bold>(B)</bold>, CD4<sup>+</sup> <bold>(C)</bold> and CD8<sup>+</sup> <bold>(D)</bold> T cell numbers in the spleen assessed by flow cytometry. Each point represents data from a single mouse. Data in the graphs are shown as means &#xb1; SD (n = at least 13 mice per group). <bold>(E)</bold> Representative flow cytometry plots of CD4<sup>+</sup> and CD8<sup>+</sup> T cells and statstical analysis of the CD4/CD8 T cell ratio in the spleen. Gating strategy is shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S8</bold>
</xref>. <bold>(F)</bold> Statistics of flow cytometric analyses showing B220<sup>+</sup> B cell numbers in the spleen. Data are merged from at least three independent experiments. *p &lt; 0.05, ***p &lt; 0.001, and ****p &lt; 0.0001. P-values were determined using a two-tailed Student&#x2019;s t test or Mann-Whitney-U test.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-889564-g002.tif"/>
</fig>
</sec>
<sec id="s3_3">
<title>CD4<sup>+</sup> T- and TFH Cell-Specific BOB.1/OBF.1 Expression Is Required for Efficient GC Formation</title>
<p>To examine the contribution of T cell-specific BOB.1/OBF.1 expression for the GC reaction, we immunized Pou2af1<sup>fl/fl</sup> mice crossed to either CD4- or IL21-Cre mice with Sheep Red Blood Cells (SRBCs). Flow-cytometric analyses of spleen and LN revealed significantly reduced levels of GL7<sup>+</sup> CD95<sup>+</sup> GC B cells after both CD4<sup>+</sup> T and TFH cell-specific BOB.1/OBF.1 deletion (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). GC B cell numbers were reduced by 60% in Pou2af1<sup>fl/fl</sup> x CD4-Cre and by 35% in Pou2af1<sup>fl/fl</sup> x IL21-Cre animals. Histological analysis of spleens confirmed the distinct reduction in the number of PNA<sup>+</sup> GCs and revealed a significant decrease in GC size for Pou2af1<sup>fl/fl</sup> x CD4-Cre mice (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). In case of Pou2af1<sup>fl/fl</sup> x IL21-Cre mice, no difference in the overall number of PNA<sup>+</sup> stained GCs compared to controls was observed, but still the GC size was significantly reduced in the TFH cell-specific conditional knockout, which probably accounts for the diminished GC B cell numbers assessed by flow cytometry (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). These findings demonstrate that the absence of GCs observed in conventional BOB.1/OBF.1-defcient mice cannot exclusively be traced back to the B cell compartment and defective B cell maturation. Our results provide evidence that specific deficiency of BOB.1/OBF.1 in T cells, while the B cell compartment stays immunocompetent, also impairs GC formation.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>CD4<sup>+</sup> T- and TFH cell-specific BOB.1/OBF.1 expression is required for efficient GC formation. <bold>(A)</bold> Representative flow cytometry plots and statistical analyses of GC B (GL7<sup>+</sup> CD95<sup>+</sup>) cell numbers in spleen and LN are shown. Gating strategy is shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S9</bold>
</xref>. <bold>(B)</bold> Representative immunohistochemical stainings of PNA<sup>+</sup> GCs for each genotype and respective Cre-controls are shown. Scale bars indicate 200 &#xb5;m. Statistical analyses showing PNA<sup>+</sup> GCs and GC size stained by immunohistochemistry. Each point represents data from a single mouse. Data in the graphs are shown as means &#xb1; SD (n= 9 mice per group). Data are merged from two independent experiments. *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, and ****p &lt; 0.0001. P-values were determined using a two-tailed Student&#x2019;s t test or Mann-Whitney-U test.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-889564-g003.tif"/>
</fig>
</sec>
<sec id="s3_4">
<title>BOB.1/OBF.1 Is Required for TFH Cell Development</title>
<p>We and others have recently shown the impact of BOB.1/OBF.1 for TFH cell development and function (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>). TFH cells provide help for B cells regulating their proliferation and immunoglobulin class switching and are therefore relevant key player during GC reaction. TFH cells are characterized by the expression of the chemokine receptor CXCR5 together with at least one of the co-receptors PD1, ICOS or BTLA4 (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B41">41</xref>). After immunization with SRBCs, both Pou2af1<sup>fl/fl</sup> mice crossed to CD4- and IL21-Cre mice revealed significantly reduced levels of CXCR5<sup>hi</sup> PD1<sup>+</sup>, CXCR5<sup>hi</sup> ICOS<sup>+</sup> and CXCR5<sup>hi</sup> BTLA4<sup>+</sup> TFH cells in the spleen and LN in comparison to respective controls (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4A&#x2013;D</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S2</bold>
</xref>). In detail, in Pou2af1<sup>fl/fl</sup> x CD4-Cre mice the frequency of CXCR5<sup>hi</sup> PD1<sup>+</sup> cells was reduced by 55%, of CXCR5<sup>hi</sup> ICOS<sup>+</sup> cells by 50% and of CXCR5<sup>hi</sup> BTLA4<sup>+</sup> cells by 30% in the spleen (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4B&#x2013;D</bold>
</xref>). For Pou2af1<sup>fl/fl</sup> x IL21-Cre mice a reduction by 40% of both CXCR5<sup>hi</sup> PD1<sup>+</sup> and CXCR5<sup>hi</sup> ICOS<sup>+</sup> cells was observed, while CXCR5<sup>hi</sup> BTLA4<sup>+</sup> cells were decreased by 35% (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4B&#x2013;D</bold>
</xref>). Besides TFH cell numbers, also their percentage of CD4<sup>+</sup> T cells was markedly reduced in both conditional knockouts in spleen and LNs (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S2</bold>
</xref>). Together, these data reveal a requirement for BOB.1/OBF.1 for efficient TFH cell development during GC response. Reduced TFH cell frequencies in Pou2af1<sup>fl/fl</sup> x IL21-Cre mice provide evidence for a TFH cell intrinsic defect in the absence of BOB.1/OBF.1 revealing that this reduction is not exclusively a consequence of defective CD4<sup>+</sup> T cell differentiation towards TFH cells.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>BOB.1/OBF.1 is required for TFH cell development. <bold>(A&#x2013;D)</bold> Representative flow cytometry plots <bold>(A)</bold> and statistical analyses of CXCR5<sup>high</sup> PD1<sup>+</sup> <bold>(B)</bold>, CXCR5<sup>high</sup> ICOS<sup>+</sup> <bold>(C)</bold> and CXCR5<sup>high</sup> BTLA4<sup>+</sup> <bold>(D)</bold> TFH cell numbers (left panel) and TFH cell percentages (right panel) of CD4<sup>+</sup> T cells in the spleen are shown. Gating strategy is shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S10</bold>
</xref>. Each point represents data from a single mouse. Data in the graphs are shown as means &#xb1; SD (n= 9 mice per group). Data are merged from two independent experiments. *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, and ****p &lt; 0.0001. P-values were determined using a two-tailed Student&#x2019;s t test or Mann-Whitney-U test.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-889564-g004.tif"/>
</fig>
</sec>
<sec id="s3_5">
<title>Ablation of BOB.1/OBF.1 in CD4<sup>+</sup> T Cells Results in Increased Treg Cell Levels and Impaired Antigen-Specific Immune Response</title>
<p>Within GCs, B cells expressing high affinity antibodies develop and differentiate into antibody secreting plasma cells (<xref ref-type="bibr" rid="B42">42</xref>). We observed a significant reduction in the number of activated CD69<sup>+</sup> B as well as antibody producing plasma cells in both conditional knockouts post immunization (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5A, B</bold>
</xref>). Since an efficient GC reaction results in the production of class-switched secondary Igs, we assessed IgM and class-switched IgG Ig levels in serum of the conditional knockout strains. For Pou2af1<sup>fl/fl</sup> x CD4-Cre mice total Ig levels were assessed during a primary and secondary immune response and measured 0, 14 and 21 days after immunization by ELISA. Despite our findings of impaired GC formation, we could not detect a striking reduction in IgM or class-switched Igs in these mice (<xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S3A</bold>
</xref>). Pou2af1<sup>fl/fl</sup> x IL21-Cre mice revealed a reduction of IgM, IgG2b and IgG3 compared to the floxed-controls, but not when compared to Cre-controls (<xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S3B</bold>
</xref>). Notably, we found a significantly increased frequency of regulatory T cells (Tregs) in Pou2af1<sup>fl/fl</sup> x CD4-Cre mice compared to controls in spleen and LNs (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S3C</bold>
</xref>). Tregs are critical for the maintenance of immune homeostasis and regulate the initiation and input to the GC response (<xref ref-type="bibr" rid="B43">43</xref>). Since we observed increased levels of Tregs, we wondered about affinity maturation and subsequent production of antigen-specific Igs upon BOB.1/OBF.1 ablation in CD4<sup>+</sup> T cells. Indeed, we could not detect significant differences in antigen-specific IgM levels, whereas levels of high-affinity anti-NP9 IgG1 and IgG3 were significantly reduced in Pou2af1<sup>fl/fl</sup> x CD4-Cre mice 28 days after immunization with NP-KLH (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5D&#x2013;F</bold>
</xref>). However, also levels of low affinity anti-NP27 antibodies of IgG1 and IgG3 isotype were significantly reduced in Pou2af1<sup>fl/fl</sup> x CD4-Cre mice (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5G</bold>
</xref>). The ratio of NP9/NP27 antibody titers can be used as an index of affinity maturation. The ratio of high-affinity to low-affinity IgG1 was significantly reduced in the conditional knockout mice 28 days after immunization, even though this defect relativized on day 49 (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5H</bold>
</xref>). The ratio of NP9/NP27 IgG3 titers was not affected in Pou2af1<sup>fl/fl</sup> x CD4-Cre mice (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5H</bold>
</xref>). In total, these data suggest a contribution of BOB.1/OBF.1 in T cells for the regulation of antigen-specific immune responses.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Ablation of BOB.1/OBF.1 in CD4<sup>+</sup> T cells results in increased Treg cell levels and reduced antigen-specific immune response. <bold>(A, B)</bold> Statistics showing numbers of activated CD69<sup>+</sup> B <bold>(A)</bold> and plasma <bold>(B)</bold> cells in the spleen after immunization. Gating strategy is shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Figures S11</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>S12</bold>
</xref> <bold>(C)</bold>. Representative flow cytometry plots and statistical analysis of Treg percentage and number in the spleen. Gating strategy is shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S13</bold>
</xref> <bold>(D&#x2013;H)</bold> ELISA of NP9-specific IgM <bold>(D)</bold>, NP9-specific IgG1 and IgG3 <bold>(E)</bold>, NP27-specific IgM <bold>(F)</bold> and NP27-specific IgG1 and IgG3 <bold>(G)</bold> in sera of mice before and after 28 days of NP-KLH immunization. Affinity maturation calculated by the ratio NP9/NP27 from day 0 to day 49 after immunization is shown <bold>(H)</bold>. Each point represents data from a single mouse. Data in the graphs are shown as means &#xb1; SD (n= at least 6 mice per group). Data are representative for two independent experiments. *p &lt; 0.05, **p &lt; 0.01, *** p&lt; 0.001, and ****p &lt; 0.0001. P-values were determined using a two-tailed Student&#x2019;s t test or Mann-Whitney-U test.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-889564-g005.tif"/>
</fig>
</sec>
<sec id="s3_6">
<title>Differential Gene Expression Between CD4<sup>+</sup> T Cells of Pou2af1<sup>fl/fl</sup> x CD4-Cre and Control Mice</title>
<p>To identify DEGs in CD4<sup>+</sup> T cells in the absence of BOB.1/OBF.1 we isolated CD4<sup>+</sup> T cells from LNs of Pou2af1<sup>fl/fl</sup> x CD4-Cre and CD4-Cre controls after immunization with SRBCs and performed RNA-seq analysis. 158 genes were significantly differentially expressed (DEGs) in Pou2af1<sup>fl/fl</sup> x CD4-Cre compared to controls at FDR 0.05 including 61 upregulated and 97 downregulated genes (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6A</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Table S2</bold>
</xref>) Hierarchical clustering analysis suggested that certain groups of the differentially expressed genes might have similar functions or might be involved in the same pathways (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref>; heatmap FDR 0.01).</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Differential gene expression between CD4<sup>+</sup> T cells of Pou2af1<sup>fl/fl</sup> x CD4-Cre and CD4-Cre control mice. CD4<sup>+</sup> T cells from immunized Pou2af1<sup>fl/fl</sup> x CD4-Cre and CD4-Cre controls were isolated from LNs and RNA-seq analysis was performed. <bold>(A)</bold> Volcano plot showing 158 DEGs at FDR 0.05 including 61 upregulated and 97 downregulated genes. The horizontal grey line indicates FDR cutoff of 0.05 and the vertical lines indicate the applied 99<sup>th</sup> percentile cutoff of the log2foldchange. <bold>(B)</bold> Heatmap showing DEGs at FDR 0.01. <bold>(C)</bold> Waterfall plot showing the top 30 DEGs at FDR 0.01. Expression of <italic>Pou2af1</italic> was excluded from the top 30 DEGs.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-889564-g006.tif"/>
</fig>
<p>Significantly enriched GO terms at FDR 0.1 were identified related to molecular function. Top hits related to molecular function contained structural molecule activity (<xref ref-type="bibr" rid="B18">18</xref>), structural constituent of ribosome (<xref ref-type="bibr" rid="B16">16</xref>), translation regulator activity (<xref ref-type="bibr" rid="B10">10</xref>), rRNA binding (<xref ref-type="bibr" rid="B9">9</xref>), translation regulator activity/nucleic acid binding (8) and translation factor activity/RNA binding (<xref ref-type="bibr" rid="B8">8</xref>) (<xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S4</bold>
</xref>). When narrowing analysis to T cell specific GO-terms, several genes associated with T cell differentiation (<xref ref-type="bibr" rid="B12">12</xref>), T cell activation (<xref ref-type="bibr" rid="B20">20</xref>) and T cell proliferation (<xref ref-type="bibr" rid="B11">11</xref>) at FDR 0.05 could be identified as differentially expressed in Pou2af1<sup>fl/fl</sup> x CD4-Cre mice (<xref ref-type="fig" rid="f7">
<bold>Figures&#xa0;7A&#x2013;C</bold>
</xref>). We also checked for the expression of key TFs and cytokines relevant for TH cell differentiation. <italic>Tbx21</italic> and <italic>Infg</italic> were downregulated (FDR &lt; 0.1) in BOB.1/OBF.1-deficient CD4<sup>+</sup> T cells confirming previous reports of reduced TH1 cytokines in conventional BOB.1/OBF.1-deficient mice and a direct contribution of BOB.1/OBF.1 to the <italic>Infg</italic> promoter (<xref ref-type="bibr" rid="B21">21</xref>) (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7D</bold>
</xref>). Consistently, three genes (<italic>Pde4d, Itk, Irf8</italic>) involved in IFN-&#x3b3; production and seven genes (<italic>Cd74</italic>, <italic>Ccl22, Ccl5, Irf8, Ifng, H2-Q7, Dapk1</italic>) involved in the response to IFN-&#x3b3; were differentially expressed at FDR &lt; 0.05 (<xref ref-type="fig" rid="f7">
<bold>Figures&#xa0;7E, F</bold>
</xref>). <italic>Rc3h1</italic> and <italic>Rc3h2</italic> associated with negative regulation of TFH and TH17 cell differentiation were upregulated in BOB.1/OBF.1-deficient CD4<sup>+</sup> T cells (FDR &lt; 0.1) (<xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S5A</bold>
</xref>). Interestingly, <italic>Rc3h1</italic> is also described as negative regulator of GC formation. However, the TFH cell signature gene <italic>Bcl-6</italic> was unaltered. In line with previous reports (<xref ref-type="bibr" rid="B24">24</xref>), <italic>Zbtb32</italic>, which encodes a transcriptional repressor of <italic>Prdm1/Blimp1</italic>, a known modulator of T cell memory, was downregulated (FDR &lt; 0.1) (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7D</bold>
</xref>). Several genes associated with Treg cell differentiation or T cell function/differentiation during GC formation could also be identified as differentially expressed, but without statistical significance (<xref ref-type="supplementary-material" rid="SM1">
<bold>Figures S5B, C</bold>
</xref>).</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>BOB.1/OBF.1 involved in TH cell differentiation. <bold>(A&#x2013;C)</bold> Waterfall plots showing differentially expressed genes between Pou2af1<sup>fl/fl</sup> x CD4-Cre and CD4-Cre control mice at FDR 0.05 related to T cell differentiation (GO:0030217) <bold>(A)</bold>, T cell activation (GO:0042110) <bold>(B)</bold> and T cell proliferation (GO:0042098) <bold>(C)</bold>. <bold>(D)</bold> Waterfall plot showing differentially expressed genes related to TH cell differentiation at FDR 0.1. Differentially expressed genes with an FDR &lt; 0.1 are highlighted with a *. <bold>(E, F)</bold> Waterfall plots showing DEGs between Pou2af1<sup>fl/fl</sup> x CD4-Cre and CD4-Cre control mice at FDR 0.05 related to IFN-&#x3b3; production (GO:0032609) <bold>(E)</bold> and related to the response to IFN-&#x3b3; (GO:0034341).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-889564-g007.tif"/>
</fig>
<p>Waterfall plot shows the top 30 DEGs in Pou2af1<sup>fl/fl</sup> x CD4-Cre mice compared to CD4-Cre controls (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6C</bold>
</xref>). The strongest DEG was <italic>2010007H06Rik</italic>, which function is unknown so far. The most interesting genes among these top 30 DEGs regarding T cell signaling and function are summarized in <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>. Interestingly in the context of BOB.1/OBF.1 being a transcriptional co-activator, four genes with DNA-binding TF activity (<italic>Sox4, Ubn2, Irf8, Irf4</italic>) were identified as differentially expressed in Pou2af1<sup>fl/fl</sup> x CD4-Cre mice. Genes associated with chemokine signaling (<italic>Ccr5, Ccl5, Ccl22</italic>) necessary for chemoattraction of T lymphocytes were all downregulated in Pou2af1<sup>fl/fl</sup> x CD4-Cre animals. Several genes associated with Treg, TFH and TH cell development (<italic>Sox4, Kmt2a, Kmt2d, Irf8, Irf4, Cd74</italic>) could be identified among the top 30 DEGs upon BOB.1/OBF.1 ablation specifically in CD4<sup>+</sup> T cells. <italic>In silico</italic> analyses revealed consensus octamer motifs within the first 3,000 bp upstream of the transcriptional start site in eight genes that are among the top 30 DEGs in Pou2af1<sup>fl/fl</sup> x CD4-Cre mice (<italic>Rab4a, Sox4, Mid1, Fasl, Crppa, Mpeg1, Cep170, Dapk1</italic>). Moreover, all other genes listed in <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref> reveal multiple putative Oct/BOB.1/OBF.1 binding sites in the promoter region that are either perfect or differ in one or two positions from the consensus site. However, all these sites harbor an adenine at position five of the octamer motif that is essential for ternary complex formation with Oct1 and BOB.1/OBF.1 (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B44">44</xref>). Three representative possible BOB.1/OBF.1 binding sites for each gene are shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S6</bold>
</xref>.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Top DEGs in Pou2af1<sup>fl/fl</sup> x CD4-Cre mice compared to CD4-Cre controls.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Gene</th>
<th valign="top" align="center">Gene Function</th>
<th valign="top" align="center">Regulation</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">
<bold>Rab4a</bold>
</td>
<td valign="top" align="left">Regulates CD4 surface expression</td>
<td valign="top" align="left">Upregulation</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Sox4</bold>
</td>
<td valign="top" align="left">TF, T cell differentiation, TFH cell differentiation</td>
<td valign="top" align="left">Upregulation</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Kmt2a</bold>
</td>
<td valign="top" align="left">TFH cell differentiation</td>
<td valign="top" align="left">Upregulation</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Kmt2d</bold>
</td>
<td valign="top" align="left">Treg development</td>
<td valign="top" align="left">Upregulation</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Irf4</bold>
</td>
<td valign="top" align="left">T helper cell activation and differentiation</td>
<td valign="top" align="left">Downregulation</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Fasl</bold>
</td>
<td valign="top" align="left">T cell apoptosis</td>
<td valign="top" align="left">Downregulation</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Mid1</bold>
</td>
<td valign="top" align="left">TCR signaling and migration of cytotoxic T cells</td>
<td valign="top" align="left">Downregulation</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Ccr5</bold>
</td>
<td valign="top" align="left">Lymphocyte migration</td>
<td valign="top" align="left">Downregulation</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Irf8</bold>
</td>
<td valign="top" align="left">TF, TFH cell regulation</td>
<td valign="top" align="left">Downregulation</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Ccl5</bold>
</td>
<td valign="top" align="left">Chemoattractant</td>
<td valign="top" align="left">Downregulation</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Ccl22</bold>
</td>
<td valign="top" align="left">Chemoattractant</td>
<td valign="top" align="left">Downregulation</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>CD74</bold>
</td>
<td valign="top" align="left">T cell activation and differentiation</td>
<td valign="top" align="left">Downregulation</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>DEGs regarding T cell signaling and function from the top30 DEGs shown in waterfall plot of <xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref> are summarized here. All genes listed in Table&#xa0;1 harbor multiple putative Oct/BOB.1/OBF.1 binding sites in the promoter region that are either perfect or differ in one or 2 positions from the consensus site.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>The GC reaction is a complex process involving several immune cell subtypes, including B and T cells. Since BOB1/OBF.1 is expressed in both lymphocyte subsets, our study aimed to finally clarify whether and how BOB.1/OBF.1 expression in T cells contributes to the GC reaction. Therefore, the <italic>in vivo</italic> function of BOB.1/OBF.1 in distinct T cell subpopulations contributing to the GC reaction was studied applying conditional mutagenesis, allowing to investigate specifically BOB.1/OBF.1 function in CD4<sup>+</sup> T or TFH cells, in the presence of immunocompetent B lymphocytes.</p>
<p>Our findings of an altered CD4/CD8 T cell ratio in Pou2af1<sup>fl/fl</sup> x CD4-Cre mice characterized by significantly reduced levels of CD4<sup>+</sup> T cells and at the same time increased levels of CD8<sup>+</sup> T cells in the periphery provide evidence for a role of BOB.1/OBF.1 in CD4<sup>+</sup> T cell biology. A reduced CD4<sup>+</sup> T cell compartment was also described analyzing conventional BOB.1/OBF.1-deficient mice (<xref ref-type="bibr" rid="B21">21</xref>). Moreover, we found significantly reduced numbers of TFH cells when BOB.1/OBF.1 expression was deleted in a CD4- or IL21-Cre dependent manner. In particular, the reduction in Pou2af1<sup>fl/fl</sup> x IL21-Cre mice shows that this is a TFH cell intrinsic defect and not exclusively a consequence of reduced CD4<sup>+</sup> T cells prior to GC formation. Since IL21 is also required for TFH cell differentiation (<xref ref-type="bibr" rid="B38">38</xref>), crossing Pou2af1<sup>fl/fl</sup> mice to IL21-Cre mice results in BOB.1/OBF.1 deficiency already in pre-TFH cells. Thus, BOB.1/OBF.1 might play a role already in pre-TFH cells and their subsequent differentiation. Our findings are contrary to the report by Yamashita et&#xa0;al., describing BOB.1/OBF.1 as a factor limiting TFH cell generation (<xref ref-type="bibr" rid="B31">31</xref>). However, it was already demonstrated that BOB.1/OBF.1 is highly expressed in TFH cells in mice and humans (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B46">46</xref>). Reduced TFH cell numbers were found in a patient with a mutation in the <italic>Pou2af1</italic> gene leading to the absence of BOB.1/OBF.1 protein (<xref ref-type="bibr" rid="B27">27</xref>). Several studies also suggested an involvement of BOB.1/OBF.1 in TFH cell development. Chevnier et&#xa0;al. reported that BOB.1/OBF.1 deficiency prevents the differentiation of CD4<sup>+</sup> T cells into TFH cells in an autoimmune mouse model (<xref ref-type="bibr" rid="B47">47</xref>). Moreover, BOB.1/OBF.1-deficient mice infected with influenza also featured reduced TFH cell numbers (<xref ref-type="bibr" rid="B23">23</xref>). However, when mice were reconstituted with BOB.1/OBF.1-deficient T and WT B cells prior to influenza infection TFH cells developed normally (<xref ref-type="bibr" rid="B23">23</xref>). Stauss et&#xa0;al. also reported a prominent reduction of TFH cells in BOB.1/OBF.1-deficient mice upon SRBC immunization and revealed a CD4<sup>+</sup> T cell autonomous defect by performing reconstitution experiments (<xref ref-type="bibr" rid="B22">22</xref>). Moreover, loss of BOB.1/OBF.1 has been found to be associated with reduced Bcl6 expression in TFH cells from mixed BM chimeras. ChIP experiments of BOB-deficient CD4<sup>+</sup> T cells maintained under TFH inducing conditions revealed binding of BOB.1/OBF.1 together with Oct-1 and Oct-2 to one of the six identified octamer motives within the <italic>Bcl6</italic> promoter (<xref ref-type="bibr" rid="B22">22</xref>). However, applying the here described genetic model we could not detect altered expression of <italic>Bcl-6</italic> in BOB.1/OBF.1-deficient CD4<sup>+</sup> T cells by RNA-seq. In contrast to Stauss et al, we utilized total CD4<sup>+</sup> T cells isolated after immunization for RNA-seq analysis instead of primary TFH or <italic>in vitro</italic> generated TFH cells, which might account for this discrepancy. Still, <italic>Rc3h1</italic> and <italic>Rc3h2</italic> associated with negative regulation of TFH differentiation were significantly upregulated in the present study. Additionally, <italic>Cxcr5</italic>, which was already shown to be cooperatively regulated by NF-&#x3ba;B, BOB.1/OBF.1 and Oct-2 in B cells, was slightly decreased on RNA level (<xref ref-type="bibr" rid="B48">48</xref>). Besides TFH cells, BOB.1/OBF.1 is also involved in the differentiation of further TH cell populations. We could already show that BOB.1/OBF.1 contributes to <italic>Infg</italic> and <italic>IL-2</italic> promoter activities in CD4<sup>+</sup> T cells thereby controlling TH1/TH2 cytokine balance (<xref ref-type="bibr" rid="B21">21</xref>). Additionally, ChIP experiments showed binding of BOB.1/OBF.1 to the consensus octamer site of the <italic>Infg</italic> promoter (<xref ref-type="bibr" rid="B22">22</xref>). BOB.1/OBF.1-deficient TH2 cells revealed reduced levels of the transcriptional factor PU.1 resulting in higher GATA3 activity and consequently higher TH2 cytokine release (<xref ref-type="bibr" rid="B21">21</xref>). Mattes et&#xa0;al. confirmed this mechanism by showing that increased BOB.1/OBF.1 expression resulted in increased PU.1 levels and a suppression of GATA3 and subsequently TH2 cytokine production (<xref ref-type="bibr" rid="B49">49</xref>). However, expression of <italic>Gata3</italic> was not markedly changed in the here presented study addressed by RNA-seq analysis. Nevertheless, RNA-seq provided further evidence for a role of BOB.1/OBF.1 in TH1 cell differentiation. <italic>Tbx21</italic> and <italic>Infg</italic> were significantly downregulated in BOB.1/OBF.1-deficient CD4<sup>+</sup> T cells and several genes involved in IFN-&#x3b3; production and in the response to IFN-&#x3b3; were significantly differentially expressed. Moreover, <italic>Irf4</italic> was significantly downregulated and was already shown to regulate TH1 responses as IRF4<sup>-/-</sup> mice show reduced T-bet and IFN-&#x3b3; expression (<xref ref-type="bibr" rid="B50">50</xref>). The role of IRF4 is certainly complex, as it is also involved in the regulation of TH2, TH9 and TH17 immune responses. As the T cell specific role of BOB.1/OBF.1 was controversially discussed in recent years, our approach of specific BOB.1/OBF.1 deletion in CD4<sup>+</sup> T and TFH cells now underlines the requirement of BOB.1/OBF.1 for TH and especially TH1 and TFH cell differentiation.</p>
<p>More interestingly, when examining the response to SRBCs, we observed significantly reduced levels of GC B cells after both CD4<sup>+</sup> T and TFH cell-specific BOB.1/OBF.1 deletion. These findings clearly indicate that the absence of GCs observed in conventional BOB.1/OBF.1-defcient mice cannot exclusively be traced back to the defective B cell compartment. Instead, our results provide evidence that BOB.1/OBF.1 expression in T cells is also required for efficient GC formation. The fact that the reduction of GCs is more prominent upon CD4<sup>+</sup> T cell specific BOB.1/OBF.1 deletion suggests that BOB.1/OBF.1 is already required during GC initiation. This is in line with findings of <italic>Pou2af1</italic> being highly expressed in early stage GC-TFH cells (<xref ref-type="bibr" rid="B51">51</xref>). As a consequence of impaired GC formation both conditional knockouts also featured markedly reduced numbers of plasma cells and activated CD69<sup>+</sup> B cells. Surprisingly, levels of total class-switched immunoglobulins were unaffected in Pou2af1<sup>fl/fl</sup> x CD4-Cre mice. However, reduced titers of NP-specific antibodies were found suggesting impaired antigen-specific immune responses in these mice. Notably, higher proportions of Tregs were found in these animals. Two studies revealed an altered expression of <italic>Pou2af1</italic> in Tregs but so far, the function of BOB.1/OBF.1 in Tregs is unknown (<xref ref-type="bibr" rid="B52">52</xref>, <xref ref-type="bibr" rid="B53">53</xref>). It was reported that Foxp3 can suppress <italic>Pou2af1</italic> expression in Tregs (<xref ref-type="bibr" rid="B54">54</xref>). Our RNA-seq analysis revealed a slight increase of FoxP3 expression and several other DEGs associated with Treg cell differentiation. Moreover, the histone methyltransferase Kmt2d, which was among the top 30 DEGs was shown to bind to FoxP3 enhancer elements thereby enabling TF binding at genes involved in Treg cell differentiation (<xref ref-type="bibr" rid="B55">55</xref>). In conclusion, the question whether BOB.1/OBF.1 is also involved in Treg physiology and therefore in regulating the balance of induction and suppression of an ongoing GC reaction remains to be elucidated.</p>
<p>In addition, RNA-seq analysis revealed further genes associated with T cell differentiation and activation among the top 30 DEGs. Genes necessary for chemoattraction of T lymphocytes (<italic>Ccr5, Ccl5, Ccl22</italic>) were all downregulated in Pou2af1<sup>fl/fl</sup> x CD4-Cre animals and revealed possible BOB.1/OBF.1 binding sites in the promoter region, which supports our findings of reduced CD4<sup>+</sup> T cell numbers in spleen and LNs. The <italic>Ccr5</italic> gene was already found to be regulated by BOB.1/OBF.1 and Oct-1 in T cells (<xref ref-type="bibr" rid="B56">56</xref>). Eight genes with consensus octamer motives could be identified among the top 30 DEGs. Among them, small GTPase Rab4a which is involved in protein transport and vesicular trafficking. Rab4a is known to regulate surface expression of CD4 <italic>via</italic> endosomal recycling and was shown to cause pro-inflammatory T cell lineage specification and to trigger autoimmunity (<xref ref-type="bibr" rid="B57">57</xref>). Sox4 is a transcriptional activator that binds with high affinity to the T cell enhancer motif 5&#x2019;-AACAAAG-3&#x2019; and is involved in T cell differentiation in the thymus (<xref ref-type="bibr" rid="B58">58</xref>). Its role in peripheral T cells and immune responses is incompletely understood. It was shown that Sox4 can be induced by TGF-&#x3b2; and negatively regulates the TF GATA-3, the master regulator of TH2 cells (<xref ref-type="bibr" rid="B59">59</xref>). Recently, increased expression of Sox4 in follicular regulatory innate lymphoid cells was identified as one mechanism to inhibit GC-TFH and GC-B cell interaction (<xref ref-type="bibr" rid="B60">60</xref>). Mid1 is a microtubule-associated ubiquitin ligase regulating protein phosphatase 2A activity (<xref ref-type="bibr" rid="B61">61</xref>). Mid1 was shown to be upregulated in cytotoxic lymphocytes controlling TCR signaling and exocytosis of lytic granules, but a function in CD4<sup>+</sup> T cells was not described to date (<xref ref-type="bibr" rid="B62">62</xref>). The expression of FasL is involved in the regulation of apoptotic and anti-apoptotic signaling pathways in T cells and FasL expression by T cells is often associated with their activation (<xref ref-type="bibr" rid="B63">63</xref>). No T cell related function is described for Crppa, Mpeg1, Cep170 and Dapk1, which also revealed consensus octamer motives. Moreover, a requirement of BOB.1/OBF.1 for the generation and function of CD4<sup>+</sup> memory T cells was described (<xref ref-type="bibr" rid="B24">24</xref>). Shakya et&#xa0;al. demonstrated that BOB.1/OBF.1 and Oct-1 localize the histone lysine demethylase Jmjd1a to targets like <italic>Il2, Ifng</italic> and <italic>Zbtb32</italic> thereby contributing to CD4<sup>+</sup> T cell memory responses (<xref ref-type="bibr" rid="B24">24</xref>). Consistently, we also identified <italic>Zbtb32</italic> as significantly downregulated in BOB.1/OBF.1-deficient CD4<sup>+</sup> T cells. Unfortunately, <italic>Il2</italic> expression could not be addressed as it was not analyzed by RNA-seq. The identification of <italic>Icosl</italic> among the top 30 DEGs is surprising, since Icosl is known to be expressed on APCs, but not on T cells. This observation might be caused by contamination with non- T cells as cells were isolated by magnetic separation. The overall purity was &#x2265; 96%, but there is one sample in the group of CD4-Cre controls which revealed slightly less purity than the other samples. Due to the low sample size in the CD4-Cre control group this might account for the differences we observe in <italic>Icosl</italic> expression. However, our observation might also support earlier findings by Wang et&#xa0;al., who were able to detect Icosl on activated T cells with their generated and verified anti-Icosl antibody (<xref ref-type="bibr" rid="B64">64</xref>). Moreover, they confirmed that <italic>Icosl</italic> transcription is induced in activated CD4<sup>+</sup> T cells by qRT-PCR. Also, other B7 family molecules, typically expressed on APCs, have been shown to be expressed also on activated T cells indicating that T cells could act as APCs to trigger the activation of neighboring or resting T cells (<xref ref-type="bibr" rid="B65">65</xref>). To finally verify these observations of Icosl expression by activated T cells, further investigations are required. Altogether, several possible BOB.1/OBF.1 regulated genes that are interesting players in T cell physiology could be identified. However, it is difficult to draw clear conclusions about the role of BOB.1/OBF.1 for their function, as most of the identified DEGs are involved in the regulation of many different partly opposing processes during T cell differentiation and function.</p>
<p>Collectively, we provide evidence that BOB.1/OBF.1 is essential in CD4<sup>+</sup> T cell biology. Our approach of specific BOB.1/OBF.1 deletion in CD4<sup>+</sup> T and TFH cells underlines the requirement of BOB.1/OBF.1 for TFH cell development and GC formation. RNA-seq analysis identified several possible BOB.1/OBF.1 target genes important for T cell differentiation.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data Availability Statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below:<uri xlink:href="https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA814427">https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA814427</uri>, accession ID: PRJNA814427.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics Statement</title>
<p>The animal study was reviewed and approved by Regierungspr&#xe4;sidium T&#xfc;bingen. Written informed consent was obtained from the owners for the participation of their animals in this study.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author Contributions</title>
<p>AB performed experiments, analyzed the data, and wrote the manuscript. JE and TK analyzed RNA-seq data. TH and TW provided advice and helped drafting the manuscript. CB designed and supervised the study and helped drafting the manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by a grant from the German Research Foundation (DFG) to CB (BR 2891/8-1).</p>
</sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We are very grateful to Gabriela Cudek, Katja Hasch, Monika Jerg and Petra Weihrich for excellent technical assistance. IL21-Cre mice were kindly provided by Dr. Uta E. H&#xf6;pken, Max-Delbr&#xfc;ck-Center for Molecular Medicine (MDC), Berlin and described by Wichner et&#xa0;al. (<xref ref-type="bibr" rid="B33">33</xref>). Sorting of TFH cells was performed by the Core Facility Cytometry of Ulm University. RNA-sequencing was performed by the Core Facility Genomics of Ulm University.</p>
</ack>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2022.889564/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2022.889564/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet_1.pdf" id="SM1" mimetype="application/pdf"/>
</sec>
<sec id="s12">
<title>Abbreviations</title>
<p>DEG, differentially expressed gene; GC, Germinal Center; LN, lymph node; Pou2af1; POU domain class 2-associating factor 1; SRBC, sheep red blood cell; TF, transcription factor; TFH, follicular T helper cells; TH cell, T-helper cell; Treg, regulatory T cells.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brunner</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wirth</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Bob.1/Obf.1 - A Critical Regulator of B Cell Function</article-title>. <source>Curr Immunol Rev</source> (<year>2006</year>) <volume>2</volume>(<issue>1</issue>):<fpage>3</fpage>&#x2013;<lpage>12</lpage>. doi: <pub-id pub-id-type="doi">10.2174/157339506775471901</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Falkner</surname> <given-names>FG</given-names>
</name>
<name>
<surname>Zachau</surname> <given-names>HG</given-names>
</name>
</person-group>. <article-title>Correct Transcription of an Immunoglobulin Kappa Gene Requires an Upstream Fragment Containing Conserved Sequence Elements</article-title>. <source>Nature</source> (<year>1984</year>) <volume>310</volume>(<issue>5972</issue>):<page-range>71&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/310071a0</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parslow</surname> <given-names>TG</given-names>
</name>
<name>
<surname>Blair</surname> <given-names>DL</given-names>
</name>
<name>
<surname>Murphy</surname> <given-names>WJ</given-names>
</name>
<name>
<surname>Granner</surname> <given-names>DK</given-names>
</name>
</person-group>. <article-title>Structure of the 5' Ends of Immunoglobulin Genes: A Novel Conserved Sequence</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>1984</year>) <volume>81</volume>(<issue>9</issue>):<page-range>2650&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.81.9.2650</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Staudt</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>H</given-names>
</name>
<name>
<surname>Sen</surname> <given-names>R</given-names>
</name>
<name>
<surname>Wirth</surname> <given-names>T</given-names>
</name>
<name>
<surname>Sharp</surname> <given-names>PA</given-names>
</name>
<name>
<surname>Baltimore</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>A Lymphoid-Specific Protein Binding to the Octamer Motif of Immunoglobulin Genes</article-title>. <source>Nature</source> (<year>1986</year>) <volume>323</volume>(<issue>6089</issue>):<page-range>640&#x2013;3</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/323640a0</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gstaiger</surname> <given-names>M</given-names>
</name>
<name>
<surname>Georgiev</surname> <given-names>O</given-names>
</name>
<name>
<surname>van Leeuwen</surname> <given-names>H</given-names>
</name>
<name>
<surname>van der Vliet</surname> <given-names>P</given-names>
</name>
<name>
<surname>Schaffner</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>The B Cell Coactivator Bob1 Shows DNA Sequence-Dependent Complex Formation With Oct-1/Oct-2 Factors, Leading to Differential Promoter Activation</article-title>. <source>EMBO J</source> (<year>1996</year>) <volume>15</volume>(<issue>11</issue>):<page-range>2781&#x2013;90</page-range>. doi: <pub-id pub-id-type="doi">10.1002/j.1460-2075.1996.tb00638.x</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Roeder</surname> <given-names>RG</given-names>
</name>
</person-group>. <article-title>Cloning, Functional Characterization, and Mechanism of Action of the B-Cell-Specific Transcriptional Coactivator Oca-B</article-title>. <source>Mol Cell Biol</source> (<year>1995</year>) <volume>15</volume>(<issue>8</issue>):<page-range>4115&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mcb.15.8.4115</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chasman</surname> <given-names>D</given-names>
</name>
<name>
<surname>Cepek</surname> <given-names>K</given-names>
</name>
<name>
<surname>Sharp</surname> <given-names>PA</given-names>
</name>
<name>
<surname>Pabo</surname> <given-names>CO</given-names>
</name>
</person-group>. <article-title>Crystal Structure of an Oca-B Peptide Bound to an Oct-1 Pou Domain/Octamer DNA Complex: Specific Recognition of a Protein-DNA Interface</article-title>. <source>Genes Dev</source> (<year>1999</year>) <volume>13</volume>(<issue>20</issue>):<page-range>2650&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1101/gad.13.20.2650</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cepek</surname> <given-names>KL</given-names>
</name>
<name>
<surname>Chasman</surname> <given-names>DI</given-names>
</name>
<name>
<surname>Sharp</surname> <given-names>PA</given-names>
</name>
</person-group>. <article-title>Sequence-Specific DNA Binding of the B-Cell-Specific Coactivator Oca-B</article-title>. <source>Genes Dev</source> (<year>1996</year>) <volume>10</volume>(<issue>16</issue>):<page-range>2079&#x2013;88</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1101/gad.10.16.2079</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname> <given-names>XF</given-names>
</name>
<name>
<surname>Reichlin</surname> <given-names>A</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Roeder</surname> <given-names>RG</given-names>
</name>
<name>
<surname>Nussenzweig</surname> <given-names>MC</given-names>
</name>
</person-group>. <article-title>Oca-B Integrates B Cell Antigen Receptor-, Cd40l- and Il 4-Mediated Signals for the Germinal Center Pathway of B Cell Development</article-title>. <source>EMBO J</source> (<year>1998</year>) <volume>17</volume>(<issue>17</issue>):<page-range>5066&#x2013;75</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/emboj/17.17.5066</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greiner</surname> <given-names>A</given-names>
</name>
<name>
<surname>Muller</surname> <given-names>KB</given-names>
</name>
<name>
<surname>Hess</surname> <given-names>J</given-names>
</name>
<name>
<surname>Pfeffer</surname> <given-names>K</given-names>
</name>
<name>
<surname>Muller-Hermelink</surname> <given-names>HK</given-names>
</name>
<name>
<surname>Wirth</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Up-Regulation of Bob.1/Obf.1 Expression in Normal Germinal Center B Cells and Germinal Center-Derived Lymphomas</article-title>. <source>Am J Pathol</source> (<year>2000</year>) <volume>156</volume>(<issue>2</issue>):<page-range>501&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0002-9440(10)64754-2</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hess</surname> <given-names>J</given-names>
</name>
<name>
<surname>Nielsen</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Fischer</surname> <given-names>K-D</given-names>
</name>
<name>
<surname>Bujard</surname> <given-names>H</given-names>
</name>
<name>
<surname>Wirth</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>The B Lymphocyte-Specific Coactivator Bob.1/Obf.1 Is Required at Multiple Stages of B-Cell Development</article-title>. <source>Mol Cell Biol</source> (<year>2001</year>) <volume>21</volume>(<issue>5</issue>):<page-range>1531&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mcb.21.5.1531-1539.2001</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Samardzic</surname> <given-names>T</given-names>
</name>
<name>
<surname>Gerlach</surname> <given-names>J</given-names>
</name>
<name>
<surname>Muller</surname> <given-names>K</given-names>
</name>
<name>
<surname>Marinkovic</surname> <given-names>D</given-names>
</name>
<name>
<surname>Hess</surname> <given-names>J</given-names>
</name>
<name>
<surname>Nitschke</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Cd22 Regulates Early B Cell Development in Bob.1/Obf.1-Deficient Mice</article-title>. <source>Eur J Immunol</source> (<year>2002</year>) <volume>32</volume>(<issue>9</issue>):<page-range>2481&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/1521-4141(200209)32:9&lt;2481::AID-IMMU2481&gt;3.0.CO;2-C</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Samardzic</surname> <given-names>T</given-names>
</name>
<name>
<surname>Marinkovic</surname> <given-names>D</given-names>
</name>
<name>
<surname>Nielsen</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Nitschke</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wirth</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Bob.1/Obf.1 Deficiency Affects Marginal-Zone B-Cell Compartment</article-title>. <source>Mol Cell Biol</source> (<year>2002</year>) <volume>22</volume>(<issue>23</issue>):<page-range>8320&#x2013;31</page-range>. doi: <pub-id pub-id-type="doi">10.1128/MCB.22.23.8320-8331.2002</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nielsen</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Georgiev</surname> <given-names>O</given-names>
</name>
<name>
<surname>Lorenz</surname> <given-names>B</given-names>
</name>
<name>
<surname>Schaffner</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>B Lymphocytes Are Impaired in Mice Lacking the Transcriptional Co-Activator Bob1/Oca-B/Obf1</article-title>. <source>Eur J Immunol</source> (<year>1996</year>) <volume>26</volume>(<issue>12</issue>):<page-range>3214&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/eji.1830261255</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Betzler</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Fiedler</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kokai</surname> <given-names>E</given-names>
</name>
<name>
<surname>Wirth</surname> <given-names>T</given-names>
</name>
<name>
<surname>Hoffmann</surname> <given-names>TK</given-names>
</name>
<name>
<surname>Brunner</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Impaired Peyer's Patch Development in Bob.1/Obf.1-Deficient Mice</article-title>. <source>Eur J Immunol</source> (<year>2021</year>) <volume>51</volume>(<issue>7</issue>):<page-range>1860&#x2013;3</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/eji.202048578</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schubart</surname> <given-names>DB</given-names>
</name>
<name>
<surname>Rolink</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kosco-Vilbois</surname> <given-names>MH</given-names>
</name>
<name>
<surname>Botteri</surname> <given-names>F</given-names>
</name>
<name>
<surname>Matthias</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>B-Cell-Specific Coactivator Obf-1/Oca-B/Bob1 Required for Immune Response and Germinal Centre Formation</article-title>. <source>Nature</source> (<year>1996</year>) <volume>383</volume>:<elocation-id>538</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/383538a0</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname> <given-names>S</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>C</given-names>
</name>
<name>
<surname>Choukrallah</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>F</given-names>
</name>
<name>
<surname>Christofori</surname> <given-names>G</given-names>
</name>
<name>
<surname>Kohler</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Obf1 and Oct Factors Control the Germinal Center Transcriptional Program</article-title>. <source>Blood</source> (<year>2021</year>) <volume>137</volume>(<issue>21</issue>):<page-range>2920&#x2013;34</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood.2020010175</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sauter</surname> <given-names>P</given-names>
</name>
<name>
<surname>Matthias</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Coactivator Obf-1 Makes Selective Contacts With Both the Pou-Specific Domain and the Pou Homeodomain and Acts as a Molecular Clamp on DNA</article-title>. <source>Mol Cell Biol</source> (<year>1998</year>) <volume>18</volume>(<issue>12</issue>):<page-range>7397&#x2013;409</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mcb.18.12.7397</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zwilling</surname> <given-names>S</given-names>
</name>
<name>
<surname>Dieckmann</surname> <given-names>A</given-names>
</name>
<name>
<surname>Pfisterer</surname> <given-names>P</given-names>
</name>
<name>
<surname>Angel</surname> <given-names>P</given-names>
</name>
<name>
<surname>Wirth</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Inducible Expression and Phosphorylation of Coactivator Bob.1/Obf.1 in T Cells</article-title>. <source>Science</source> (<year>1997</year>) <volume>277</volume>(<issue>5323</issue>):<page-range>221&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.277.5323.221</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mueller</surname> <given-names>K</given-names>
</name>
<name>
<surname>Quandt</surname> <given-names>J</given-names>
</name>
<name>
<surname>Marienfeld</surname> <given-names>RB</given-names>
</name>
<name>
<surname>Weihrich</surname> <given-names>P</given-names>
</name>
<name>
<surname>Fiedler</surname> <given-names>K</given-names>
</name>
<name>
<surname>Claussnitzer</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Octamer-Dependent Transcription in T Cells Is Mediated by Nfat and Nf-Kb</article-title>. <source>Nucleic Acids Res</source> (<year>2013</year>) <volume>41</volume>(<issue>4</issue>):<page-range>2138&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gks1349</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brunner</surname> <given-names>C</given-names>
</name>
<name>
<surname>Sindrilaru</surname> <given-names>A</given-names>
</name>
<name>
<surname>Girkontaite</surname> <given-names>I</given-names>
</name>
<name>
<surname>Fischer</surname> <given-names>KD</given-names>
</name>
<name>
<surname>Sunderk&#xf6;tter</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wirth</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Bob.1/Obf.1 Controls the Balance of Th1 and Th2 Immune Responses</article-title>. <source>EMBO J</source> (<year>2007</year>) <volume>26</volume>(<issue>13</issue>):<page-range>3191&#x2013;202</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/sj.emboj.7601742</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stauss</surname> <given-names>D</given-names>
</name>
<name>
<surname>Brunner</surname> <given-names>C</given-names>
</name>
<name>
<surname>Berberich-Siebelt</surname> <given-names>F</given-names>
</name>
<name>
<surname>Hopken</surname> <given-names>UE</given-names>
</name>
<name>
<surname>Lipp</surname> <given-names>M</given-names>
</name>
<name>
<surname>Muller</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>The Transcriptional Coactivator Bob1 Promotes the Development of Follicular T Helper Cells <italic>Via</italic> Bcl6</article-title>. <source>EMBO J</source> (<year>2016</year>) <volume>35</volume>(<issue>8</issue>):<page-range>881&#x2013;98</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.15252/embj.201591459</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karnowski</surname> <given-names>A</given-names>
</name>
<name>
<surname>Chevrier</surname> <given-names>S</given-names>
</name>
<name>
<surname>Belz</surname> <given-names>GT</given-names>
</name>
<name>
<surname>Mount</surname> <given-names>A</given-names>
</name>
<name>
<surname>Emslie</surname> <given-names>D</given-names>
</name>
<name>
<surname>D'Costa</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>B and T Cells Collaborate in Antiviral Responses <italic>Via</italic> Il-6, Il-21, and Transcriptional Activator and Coactivator, Oct2 and Obf-1</article-title>. <source>J Exp Med</source> (<year>2012</year>) <volume>209</volume>(<issue>11</issue>):<page-range>2049&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.20111504</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shakya</surname> <given-names>A</given-names>
</name>
<name>
<surname>Goren</surname> <given-names>A</given-names>
</name>
<name>
<surname>Shalek</surname> <given-names>A</given-names>
</name>
<name>
<surname>German</surname> <given-names>CN</given-names>
</name>
<name>
<surname>Snook</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kuchroo</surname> <given-names>VK</given-names>
</name>
<etal/>
</person-group>. <article-title>Oct1 and Oca-B Are Selectively Required for Cd4 Memory T Cell Function</article-title>. <source>J Exp Med</source> (<year>2015</year>) <volume>212</volume>(<issue>12</issue>):<page-range>2115&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.20150363</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ikegami</surname> <given-names>I</given-names>
</name>
<name>
<surname>Takaki</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kamiya</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kamekura</surname> <given-names>R</given-names>
</name>
<name>
<surname>Ichimiya</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Bob1 Enhances Ror&#x3b3;t-Mediated Il-17a Expression in Th17 Cells Through Interaction With Ror&#x3b3;t</article-title>. <source>Biochem Biophys Res Commun</source> (<year>2019</year>) <volume>514</volume>(<issue>4</issue>):<page-range>1167&#x2013;71</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbrc.2019.05.057</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yosef</surname> <given-names>N</given-names>
</name>
<name>
<surname>Shalek</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Gaublomme</surname> <given-names>JT</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>H</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Awasthi</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Dynamic Regulatory Network Controlling Th17 Cell Differentiation</article-title>. <source>Nature</source> (<year>2013</year>) <volume>496</volume>(<issue>7446</issue>):<page-range>461&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature11981</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kury</surname> <given-names>P</given-names>
</name>
<name>
<surname>Staniek</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wegehaupt</surname> <given-names>O</given-names>
</name>
<name>
<surname>Janowska</surname> <given-names>I</given-names>
</name>
<name>
<surname>Eckenweiler</surname> <given-names>M</given-names>
</name>
<name>
<surname>Korinthenberg</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Agammaglobulinemia With Normal B-Cell Numbers in a Patient Lacking Bob1</article-title>. <source>J Allergy Clin Immunol</source> (<year>2021</year>) <volume>147</volume>(<issue>5</issue>):<page-range>1977&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jaci.2021.01.027</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levels</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Van Tok</surname> <given-names>MN</given-names>
</name>
<name>
<surname>Cantaert</surname> <given-names>T</given-names>
</name>
<name>
<surname>Ca&#xf1;ete</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Kroese</surname> <given-names>FG</given-names>
</name>
<name>
<surname>Germar</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>The Transcriptional Coactivator Bob1 Is Associated With Pathologic B Cell Responses in Autoimmune Tissue Inflammation</article-title>. <source>Arthritis Rheumatol (Hoboken NJ)</source> (<year>2017</year>) <volume>69</volume>(<issue>4</issue>):<page-range>750&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/art.39993</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yeremenko</surname> <given-names>N</given-names>
</name>
<name>
<surname>Danger</surname> <given-names>R</given-names>
</name>
<name>
<surname>Baeten</surname> <given-names>D</given-names>
</name>
<name>
<surname>Tomilin</surname> <given-names>A</given-names>
</name>
<name>
<surname>Brouard</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Transcriptional Regulator Bob.1: Molecular Mechanisms and Emerging Role in Chronic Inflammation and Autoimmunity</article-title>. <source>Autoimmun Rev</source> (<year>2021</year>) <volume>20</volume>(<issue>6</issue>):<elocation-id>102833</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.autrev.2021.102833</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>H</given-names>
</name>
<name>
<surname>Perovanovic</surname> <given-names>J</given-names>
</name>
<name>
<surname>Shakya</surname> <given-names>A</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>Z</given-names>
</name>
<name>
<surname>German</surname> <given-names>CN</given-names>
</name>
<name>
<surname>Ibarra</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Targeting Transcriptional Coregulator Oca-B/Pou2af1 Blocks Activated Autoreactive T Cells in the Pancreas and Type 1 Diabetes</article-title>. <source>J Exp Med</source> (<year>2021</year>) <volume>218</volume>(<issue>3</issue>). doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.20200533</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamashita</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kawata</surname> <given-names>K</given-names>
</name>
<name>
<surname>Matsumiya</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kamekura</surname> <given-names>R</given-names>
</name>
<name>
<surname>Jitsukawa</surname> <given-names>S</given-names>
</name>
<name>
<surname>Nagaya</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Bob1 Limits Cellular Frequency of T-Follicular Helper Cells</article-title>. <source>Eur J Immunol</source> (<year>2016</year>) <volume>46</volume>(<issue>6</issue>):<page-range>1361&#x2013;70</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/eji.201545499</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>PP</given-names>
</name>
<name>
<surname>Fitzpatrick</surname> <given-names>DR</given-names>
</name>
<name>
<surname>Beard</surname> <given-names>C</given-names>
</name>
<name>
<surname>Jessup</surname> <given-names>HK</given-names>
</name>
<name>
<surname>Lehar</surname> <given-names>S</given-names>
</name>
<name>
<surname>Makar</surname> <given-names>KW</given-names>
</name>
<etal/>
</person-group>. <article-title>A Critical Role for Dnmt1 and DNA Methylation in T Cell Development, Function, and Survival</article-title>. <source>Immunity</source> (<year>2001</year>) <volume>15</volume>(<issue>5</issue>):<page-range>763&#x2013;74</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s1074-7613(01)00227-8</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wichner</surname> <given-names>K</given-names>
</name>
<name>
<surname>Stauss</surname> <given-names>D</given-names>
</name>
<name>
<surname>Kampfrath</surname> <given-names>B</given-names>
</name>
<name>
<surname>Kr&#xfc;ger</surname> <given-names>K</given-names>
</name>
<name>
<surname>M&#xfc;ller</surname> <given-names>G</given-names>
</name>
<name>
<surname>Rehm</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Dysregulated Development of Il-17- and Il-21-Expressing Follicular Helper T Cells and Increased Germinal Center Formation in the Absence of Ror&#x3b3;t</article-title>. <source>FASEB J</source> (<year>2016</year>) <volume>30</volume>(<issue>2</issue>):<page-range>761&#x2013;74</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1096/fj.15-274001</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Betzler</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Fiedler</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hoffmann</surname> <given-names>TK</given-names>
</name>
<name>
<surname>Fehling</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Wirth</surname> <given-names>T</given-names>
</name>
<name>
<surname>Brunner</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Bob.1/Obf.1 Is Required During B-Cell Ontogeny for B-Cell Differentiation and Germinal Center Function</article-title>. <source>Eur J Immunol</source> (<year>2021</year>) <volume>52</volume>(<issue>3</issue>):<page-range>404&#x2013;17</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/eji.202149333</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ibrahim</surname> <given-names>JG</given-names>
</name>
<name>
<surname>Love</surname> <given-names>MI</given-names>
</name>
</person-group>. <article-title>Heavy-Tailed Prior Distributions for Sequence Count Data: Removing the Noise and Preserving Large Differences</article-title>. <source>Bioinf (Oxford England)</source> (<year>2019</year>) <volume>35</volume>(<issue>12</issue>):<page-range>2084&#x2013;92</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/bioinformatics/bty895</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname> <given-names>L</given-names>
</name>
<name>
<surname>Laurence</surname> <given-names>A</given-names>
</name>
<name>
<surname>Elias</surname> <given-names>KM</given-names>
</name>
<name>
<surname>O'Shea</surname> <given-names>JJ</given-names>
</name>
</person-group>. <article-title>Il-21 Is Produced by Th17 Cells and Drives Il-17 Production in a Stat3-Dependent Manner</article-title>. <source>J Biol Chem</source> (<year>2007</year>) <volume>282</volume>(<issue>48</issue>):<page-range>34605&#x2013;10</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M705100200</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coquet</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Kyparissoudis</surname> <given-names>K</given-names>
</name>
<name>
<surname>Pellicci</surname> <given-names>DG</given-names>
</name>
<name>
<surname>Besra</surname> <given-names>G</given-names>
</name>
<name>
<surname>Berzins</surname> <given-names>SP</given-names>
</name>
<name>
<surname>Smyth</surname> <given-names>MJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Il-21 Is Produced by Nkt Cells and Modulates Nkt Cell Activation and Cytokine Production</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>178</volume>(<issue>5</issue>):<page-range>2827&#x2013;34</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.178.5.2827</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nurieva</surname> <given-names>RI</given-names>
</name>
<name>
<surname>Chung</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Hwang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>XO</given-names>
</name>
<name>
<surname>Kang</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Generation of T Follicular Helper Cells Is Mediated by Interleukin-21 But Independent of T Helper 1, 2, or 17 Cell Lineages</article-title>. <source>Immunity</source> (<year>2008</year>) <volume>29</volume>(<issue>1</issue>):<page-range>138&#x2013;49</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2008.05.009</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Roeder</surname> <given-names>RG</given-names>
</name>
</person-group>. <article-title>Identification and Characterization of a Novel Oca-B Isoform: Implications for a Role in B Cell Signaling Pathways</article-title>. <source>Immunity</source> (<year>2001</year>) <volume>14</volume>(<issue>2</issue>):<page-range>157&#x2013;67</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S1074-7613(01)00099-1</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Westendorf</surname> <given-names>K</given-names>
</name>
<name>
<surname>Durek</surname> <given-names>P</given-names>
</name>
<name>
<surname>Ayew</surname> <given-names>S</given-names>
</name>
<name>
<surname>Mashreghi</surname> <given-names>MF</given-names>
</name>
<name>
<surname>Radbruch</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Chromosomal Localisation of the Cd4cre Transgene in B6&#xb7;Cg-Tg(Cd4-Cre)1cwi Mice</article-title>. <source>J Immunol Methods</source> (<year>2016</year>) <volume>436</volume>:<page-range>54&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jim.2016.06.005</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zou</surname> <given-names>L</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>YC</given-names>
</name>
</person-group>. <article-title>T Follicular Helper Cells, T Follicular Regulatory Cells and Autoimmunity</article-title>. <source>Int Immunol</source> (<year>2016</year>) <volume>28</volume>(<issue>4</issue>):<page-range>173&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/intimm/dxv079</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Silva</surname> <given-names>NS</given-names>
</name>
<name>
<surname>Klein</surname> <given-names>U</given-names>
</name>
</person-group>. <article-title>Dynamics of B Cells in Germinal Centres</article-title>. <source>Nat Rev Immunol</source> (<year>2015</year>) <volume>15</volume>(<issue>3</issue>):<page-range>137&#x2013;48</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri3804</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vanderleyden</surname> <given-names>I</given-names>
</name>
<name>
<surname>Linterman</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>KG</given-names>
</name>
</person-group>. <article-title>Regulatory T Cells and Control of the Germinal Centre Response</article-title>. <source>Arthritis Res Ther</source> (<year>2014</year>) <volume>16</volume>(<issue>5</issue>):<elocation-id>471</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13075-014-0471-7</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pevzner</surname> <given-names>V</given-names>
</name>
<name>
<surname>Kraft</surname> <given-names>R</given-names>
</name>
<name>
<surname>Kostka</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lipp</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Phosphorylation of Oct-2 at Sites Located in the Pou Domain Induces Differential Down-Regulation of Oct-2 DNA-Binding Ability</article-title>. <source>Biochem J</source> (<year>2000</year>) <volume>347 Pt 1</volume>(<issue>Pt 1</issue>):<fpage>29</fpage>&#x2013;<lpage>35</lpage>. doi: <pub-id pub-id-type="doi">10.1042/bj3470029</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chtanova</surname> <given-names>T</given-names>
</name>
<name>
<surname>Tangye</surname> <given-names>SG</given-names>
</name>
<name>
<surname>Newton</surname> <given-names>R</given-names>
</name>
<name>
<surname>Frank</surname> <given-names>N</given-names>
</name>
<name>
<surname>Hodge</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Rolph</surname> <given-names>MS</given-names>
</name>
<etal/>
</person-group>. <article-title>T Follicular Helper Cells Express a Distinctive Transcriptional Profile, Reflecting Their Role as Non-Th1/Th2 Effector Cells That Provide Help for B Cells</article-title>. <source>J Immunol</source> (<year>2004</year>) <volume>173</volume>(<issue>1</issue>):<fpage>68</fpage>&#x2013;<lpage>78</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.173.1.68</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Locci</surname> <given-names>M</given-names>
</name>
<name>
<surname>Havenar-Daughton</surname> <given-names>C</given-names>
</name>
<name>
<surname>Landais</surname> <given-names>E</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kroenke Mark</surname> <given-names>A</given-names>
</name>
<name>
<surname>Arlehamn Cecilia</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Human Circulating Pd-1+Cxcr3-Cxcr5+ Memory Tfh Cells Are Highly Functional and Correlate With Broadly Neutralizing Hiv Antibody Responses</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>39</volume>(<issue>4</issue>):<page-range>758&#x2013;69</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2013.08.031</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chevrier</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kratina</surname> <given-names>T</given-names>
</name>
<name>
<surname>Emslie</surname> <given-names>D</given-names>
</name>
<name>
<surname>Karnowski</surname> <given-names>A</given-names>
</name>
<name>
<surname>Corcoran</surname> <given-names>LM</given-names>
</name>
</person-group>. <article-title>Germinal Center-Independent, Igm-Mediated Autoimmunity in Sanroque Mice Lacking Obf1</article-title>. <source>Immunol Cell Biol</source> (<year>2014</year>) <volume>92</volume>(<issue>1</issue>):<page-range>12&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/icb.2013.71</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wolf</surname> <given-names>I</given-names>
</name>
<name>
<surname>Pevzner</surname> <given-names>V</given-names>
</name>
<name>
<surname>Kaiser</surname> <given-names>E</given-names>
</name>
<name>
<surname>Bernhardt</surname> <given-names>G</given-names>
</name>
<name>
<surname>Claudio</surname> <given-names>E</given-names>
</name>
<name>
<surname>Siebenlist</surname> <given-names>U</given-names>
</name>
<etal/>
</person-group>. <article-title>Downstream Activation of a Tata-Less Promoter by Oct-2, Bob1, and Nf-Kappab Directs Expression of the Homing Receptor Blr1 to Mature B Cells</article-title>. <source>J Biol Chem</source> (<year>1998</year>) <volume>273</volume>(<issue>44</issue>):<page-range>28831&#x2013;6</page-range>. doi: <pub-id pub-id-type="doi">10.1074/jbc.273.44.28831</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mattes</surname> <given-names>J</given-names>
</name>
<name>
<surname>Collison</surname> <given-names>A</given-names>
</name>
<name>
<surname>Plank</surname> <given-names>M</given-names>
</name>
<name>
<surname>Phipps</surname> <given-names>S</given-names>
</name>
<name>
<surname>Foster</surname> <given-names>PS</given-names>
</name>
</person-group>. <article-title>Antagonism of Microrna-126 Suppresses the Effector Function of Th2 Cells and the Development of Allergic Airways Disease</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2009</year>) <volume>106</volume>(<issue>44</issue>):<page-range>18704&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.0905063106</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahnke</surname> <given-names>J</given-names>
</name>
<name>
<surname>Schumacher</surname> <given-names>V</given-names>
</name>
<name>
<surname>Ahrens</surname> <given-names>S</given-names>
</name>
<name>
<surname>K&#xe4;ding</surname> <given-names>N</given-names>
</name>
<name>
<surname>Feldhoff</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Huber</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Interferon Regulatory Factor 4 Controls Th1 Cell Effector Function and Metabolism</article-title>. <source>Sci Rep</source> (<year>2016</year>) <volume>6</volume>(<issue>1</issue>):<elocation-id>35521</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/srep35521</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname> <given-names>YS</given-names>
</name>
<name>
<surname>Gullicksrud</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Xing</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Shan</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Li</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Lef-1 and Tcf-1 Orchestrate Tfh Differentiation by Regulating Differentiation Circuits Upstream of the Transcriptional Repressor Bcl6</article-title>. <source>Nat Immunol</source> (<year>2015</year>) <volume>16</volume>(<issue>9</issue>):<page-range>980&#x2013;90</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.3226</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wing</surname> <given-names>JB</given-names>
</name>
<name>
<surname>Kitagawa</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Locci</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hume</surname> <given-names>H</given-names>
</name>
<name>
<surname>Tay</surname> <given-names>C</given-names>
</name>
<name>
<surname>Morita</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>A Distinct Subpopulation of Cd25(-) T-Follicular Regulatory Cells Localizes in the Germinal Centers</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2017</year>) <volume>114</volume>(<issue>31</issue>):<page-range>E6400&#x2013;e9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1705551114</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Metenou</surname> <given-names>S</given-names>
</name>
<name>
<surname>Coulibaly</surname> <given-names>YI</given-names>
</name>
<name>
<surname>Sturdevant</surname> <given-names>D</given-names>
</name>
<name>
<surname>Dolo</surname> <given-names>H</given-names>
</name>
<name>
<surname>Diallo</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Soumaoro</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Highly Heterogeneous, Activated, and Short-Lived Regulatory T Cells During Chronic Filarial Infection</article-title>. <source>Eur J Immunol</source> (<year>2014</year>) <volume>44</volume>(<issue>7</issue>):<page-range>2036&#x2013;47</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/eji.201444452</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marson</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kretschmer</surname> <given-names>K</given-names>
</name>
<name>
<surname>Frampton</surname> <given-names>GM</given-names>
</name>
<name>
<surname>Jacobsen</surname> <given-names>ES</given-names>
</name>
<name>
<surname>Polansky</surname> <given-names>JK</given-names>
</name>
<name>
<surname>MacIsaac</surname> <given-names>KD</given-names>
</name>
<etal/>
</person-group>. <article-title>Foxp3 Occupancy and Regulation of Key Target Genes During T-Cell Stimulation</article-title>. <source>Nature</source> (<year>2007</year>) <volume>445</volume>(<issue>7130</issue>):<page-range>931&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature05478</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Placek</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>G</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>K</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Ding</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>JE</given-names>
</name>
<etal/>
</person-group>. <article-title>MLL4 Prepares the Enhancer Landscape for Foxp3 Induction via Chromatin Looping</article-title>. <source>Nat Immunol</source> (<year>2017</year>) <volume>18</volume>(<issue>9</issue>):<page-range>1035&#x2013;45</page-range>. doi: <pub-id pub-id-type="doi">10.1038/ni.3812</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moriuchi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Moriuchi</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Octamer Transcription Factors Up-Regulate the Expression of Ccr5, a Coreceptor for Hiv-1 Entry *</article-title>. <source>J Biol Chem</source> (<year>2001</year>) <volume>276</volume>(<issue>12</issue>):<page-range>8639&#x2013;42</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M008391200</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caza</surname> <given-names>TN</given-names>
</name>
<name>
<surname>Fernandez</surname> <given-names>DR</given-names>
</name>
<name>
<surname>Talaber</surname> <given-names>G</given-names>
</name>
<name>
<surname>Oaks</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Haas</surname> <given-names>M</given-names>
</name>
<name>
<surname>Madaio</surname> <given-names>MP</given-names>
</name>
<etal/>
</person-group>. <article-title>HRES-1/Rab4-Mediated Depletion of Drp1 Impairs Mitochondrial Homeostasis and Represents a Target for Treatment in SLE</article-title>. <source>Ann Rheum Dis</source> (<year>2014</year>) <volume>73</volume>(<supplement>10</supplement>):<page-range>1888&#x2013;97</page-range>. doi: <pub-id pub-id-type="doi">10.1136/annrheumdis-2013-203794</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van de Wetering</surname> <given-names>M</given-names>
</name>
<name>
<surname>Oosterwegel</surname> <given-names>M</given-names>
</name>
<name>
<surname>van Norren</surname> <given-names>K</given-names>
</name>
<name>
<surname>Clevers</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Sox-4, an Sry-Like Hmg Box Protein, Is a Transcriptional Activator in Lymphocytes</article-title>. <source>EMBO J</source> (<year>1993</year>) <volume>12</volume>(<issue>10</issue>):<page-range>3847&#x2013;54</page-range>. doi: <pub-id pub-id-type="doi">10.1002/j.1460-2075.1993.tb06063.x</pub-id>
</citation>
</ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuwahara</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yamashita</surname> <given-names>M</given-names>
</name>
<name>
<surname>Shinoda</surname> <given-names>K</given-names>
</name>
<name>
<surname>Tofukuji</surname> <given-names>S</given-names>
</name>
<name>
<surname>Onodera</surname> <given-names>A</given-names>
</name>
<name>
<surname>Shinnakasu</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>The Transcription Factor Sox4 Is a Downstream Target of Signaling by the Cytokine Tgf-B and Suppresses T(H)2 Differentiation</article-title>. <source>Nat Immunol</source> (<year>2012</year>) <volume>13</volume>(<issue>8</issue>):<page-range>778&#x2013;86</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.2362</pub-id>
</citation>
</ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O&#x2019;Connor</surname> <given-names>MH</given-names>
</name>
<name>
<surname>Muir</surname> <given-names>R</given-names>
</name>
<name>
<surname>Chakhtoura</surname> <given-names>M</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Moysi</surname> <given-names>E</given-names>
</name>
<name>
<surname>Moir</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>A Follicular Regulatory Innate Lymphoid Cell Population Impairs Interactions Between Germinal Center Tfh and B Cells</article-title>. <source>Commun Biol</source> (<year>2021</year>) <volume>4</volume>(<issue>1</issue>):<fpage>563</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s42003-021-02079-0</pub-id>
</citation>
</ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trockenbacher</surname> <given-names>A</given-names>
</name>
<name>
<surname>Suckow</surname> <given-names>V</given-names>
</name>
<name>
<surname>Foerster</surname> <given-names>J</given-names>
</name>
<name>
<surname>Winter</surname> <given-names>J</given-names>
</name>
<name>
<surname>Krauss</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ropers</surname> <given-names>HH</given-names>
</name>
<etal/>
</person-group>. <article-title>Mid1, Mutated in Opitz Syndrome, Encodes an Ubiquitin Ligase That Targets Phosphatase 2a for Degradation</article-title>. <source>Nat Genet</source> (<year>2001</year>) <volume>29</volume>(<issue>3</issue>):<page-range>287&#x2013;94</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ng762</pub-id>
</citation>
</ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boding</surname> <given-names>L</given-names>
</name>
<name>
<surname>Hansen</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Meroni</surname> <given-names>G</given-names>
</name>
<name>
<surname>Johansen</surname> <given-names>BB</given-names>
</name>
<name>
<surname>Braunstein</surname> <given-names>TH</given-names>
</name>
<name>
<surname>Bonefeld</surname> <given-names>CM</given-names>
</name>
<etal/>
</person-group>. <article-title>Midline 1 Directs Lytic Granule Exocytosis and Cytotoxicity of Mouse Killer T Cells</article-title>. <source>Eur J Immunol</source> (<year>2014</year>) <volume>44</volume>(<issue>10</issue>):<page-range>3109&#x2013;18</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/eji.201344388</pub-id>
</citation>
</ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamada</surname> <given-names>A</given-names>
</name>
<name>
<surname>Arakaki</surname> <given-names>R</given-names>
</name>
<name>
<surname>Saito</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kudo</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ishimaru</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Dual Role of Fas/Fasl-Mediated Signal in Peripheral Immune Tolerance</article-title>. <source>Front Immunol</source> (<year>2017</year>) <volume>8</volume>:<elocation-id>403</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2017.00403</pub-id>
</citation>
</ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>F</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>T</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Ju</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ju</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>The Expression Analysis of Icos-L on Activated T Cells and Immature Dendritic Cells as Well as Malignant B Cells and Grave's-Disease-Derived Thyroid Tissues by Two Novel Mabs Against Human Icos-L</article-title>. <source>Tissue Antigens</source> (<year>2007</year>) <volume>69</volume>(<issue>1</issue>):<fpage>62</fpage>&#x2013;<lpage>72</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1399-0039.2006.00706.x</pub-id>
</citation>
</ref>
<ref id="B65">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>Z-W</given-names>
</name>
<name>
<surname>Qiu</surname> <given-names>Y-H</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>Y-J</given-names>
</name>
<name>
<surname>Tao</surname> <given-names>R</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ge</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Time Courses of B7 Family Molecules Expressed on Activated T-Cells and Their Biological Significance</article-title>. <source>Cell Immunol</source> (<year>2005</year>) <volume>236</volume>(<issue>1</issue>):<page-range>146&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cellimm.2005.08.021</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>